Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

During a live event, Mojtaba Akhtari, MD, discussed the goals and treatment approach for patients with low-risk polycythemia ...

Panelists report that the AUGMENT-101 trial demonstrated meaningful clinical benefits of menin inhibitors in ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb ...

The purge of probationary federal workers included skilled lab personnel who would have finalized a customized cell immunotherapy for cancer patients.

A novel assay will allow clinicians to analyze neonatal immune status in real-time using a single drop of blood, according to ...

In a summer of increased need for blood donations, the American Red Cross hosted its first Pride in Every Drop drive to help ...

Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, supporting further development.